Stay updated on Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe page now shows a 403 Forbidden error page, and the detailed study record content is no longer visible.SummaryDifference18%

- Check13 days agoChange DetectedPage revision updated from v3.6.6 to v3.7.0, indicating a new version of the site software. This change does not modify the study information visible on the page.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new page revision number was added (v3.6.6) replacing the previous (v3.6.5). This indicates an internal update to the page version rather than a change to study information.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a new build of the ClinicalTrials.gov entry.SummaryDifference0.1%

- Check70 days agoChange DetectedThe site template was updated to version v3.6.4, reflecting an internal revision to the page framework. No substantive study information appears to have changed.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page now lists Revision: v3.6.3, replacing the prior v3.6.0. This indicates a backend or formatting update without changing the study details.SummaryDifference0.1%

Stay in the know with updates to Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page.